Literature DB >> 15601362

Diabetes in an infant with cystic fibrosis.

Francesca Lombardi1, Valeria Raia, Maria Immacolata Spagnuolo, Rosa Nugnes, Giuliana Valerio, Giuseppe Ciccarelli, Adriana Franzese.   

Abstract

Cystic fibrosis (CF)-related diabetes mellitus is an unusual complication in very young pediatric patients with CF. It is generally associated with more severe clinical manifestations of CF. In this report, we describe a case of diabetes and CF starting in infancy. The patient manifested a form of intermittent diabetes without fasting hyperglycemia, which was exacerbated by steroid treatment during pulmonary disease and occasionally required insulin therapy. Insulin responses to oral and intravenous glucose challenge were low. The clinical and radiological status was stable during the 9-yr follow-up. Our patient demonstrates that diabetes may not only represent a complication of CF, as previously maintained, but can also be a co-morbid condition proceeding along with the exocrine disease. The early occurrence of hyperglycemia in this case may highlight an impairment of beta-cell function, which might be genetically determined. Careful monitoring of the glucose profile and of beta-cell function is indicated in patients with CF to avoid late recognition of diabetes.

Entities:  

Mesh:

Year:  2004        PMID: 15601362     DOI: 10.1111/j.1399-543X.2004.00069.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  6 in total

Review 1.  Channeling dysglycemia: ion-channel variations perturbing glucose homeostasis.

Authors:  Jerod Scott Denton; David Aaron Jacobson
Journal:  Trends Endocrinol Metab       Date:  2011-11-29       Impact factor: 12.015

2.  A Transient Metabolic Recovery from Early Life Glucose Intolerance in Cystic Fibrosis Ferrets Occurs During Pancreatic Remodeling.

Authors:  Yaling Yi; Xingshen Sun; Katherine Gibson-Corley; Weiliang Xie; Bo Liang; Nan He; Scott R Tyler; Aliye Uc; Louis H Philipson; Kai Wang; Manami Hara; Katie Larson Ode; Andrew W Norris; John F Engelhardt
Journal:  Endocrinology       Date:  2016-02-10       Impact factor: 4.736

Review 3.  Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review.

Authors:  Antoinette Moran; Dorothy Becker; Samuel J Casella; Peter A Gottlieb; M Sue Kirkman; Bruce C Marshall; Bonnie Slovis
Journal:  Diabetes Care       Date:  2010-12       Impact factor: 19.112

4.  Structural abnormalities in islets from very young children with cystic fibrosis may contribute to cystic fibrosis-related diabetes.

Authors:  Marika Bogdani; Scott M Blackman; Cecilia Ridaura; Jean-Pierre Bellocq; Alvin C Powers; Lydia Aguilar-Bryan
Journal:  Sci Rep       Date:  2017-12-08       Impact factor: 4.379

5.  Long-Term Follow-Up in a Girl with Cystic Fibrosis and Diabetes Since the First Year of Life.

Authors:  Valentina Fattorusso; Alida Casale; Valeria Raia; Enza Mozzillo; Adriana Franzese
Journal:  Diabetes Ther       Date:  2017-08-02       Impact factor: 2.945

6.  Short-term CFTR inhibition reduces islet area in C57BL/6 mice.

Authors:  Dawood Khan; Ryan Kelsey; Rashmi R Maheshwari; Virginia M Stone; Annie Hasib; Fiona N Manderson Koivula; Aoife Watson; Stephen Harkin; Nigel Irwin; James A Shaw; Neville H McClenaghan; Viktória Venglovecz; Attila Ébert; Malin Flodström-Tullberg; Michael G White; Catriona Kelly
Journal:  Sci Rep       Date:  2019-08-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.